Share
Market Research Report

KEYTRUDA MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Treatment RegimenMonotherapy and Combination therapy
  • By IndicationMelanoma · Non Small Cell Lung Cancer (NSCLC) · Malignant Pleural Mesothelioma (MPM) · Head and Neck Squamous Cell Carcinoma (HNSCC) · Classical Hodgkin Lymphoma (cHL) · Primary Mediastinal Large B Cell Lymphoma (PMBCL) · Urothelial Cancer · Microsatellite Instability High/Mismatch Repair Deficient (MSI H/dMMR) Solid Tumors · MSI H/dMMR Colorectal Cancer (CRC) · Gastric Adenocarcinoma/Gastroesophageal Junction (GEJ) Cancer · Esophageal/GEJ Carcinoma · Cervical Cancer · Hepatocellular Carcinoma (HCC) · Biliary Tract Cancer (BTC) · Merkel Cell Carcinoma (MCC) · Renal Cell Carcinoma (RCC) · Endometrial Carcinoma · Tumor Mutational Burden High (TMB H) Solid Tumors · Cutaneous Squamous Cell Carcinoma (cSCC) · and Triple Negative Breast Cancer (TNBC)
  • By Dosage RegimenFixed-Dose (Adult) (200 mg every 3 weeks, 400 mg every 6 weeks) · Weight-Based (Pediatric) · and 2 mg/kg (up to 200 mg) every 3 weeks
  • By Payer TypePublic and Private
  • By GenderMale and Female
  • By Distribution ChannelHospital pharmacies · Specialty/Retail pharmacies · and Online pharmacies
  • By End UserHospitals · Academic and Research Cancer Centers · Specialty Cancer Clinics · and Ambulatory Infusion Centers
  • By GeographyNorth America · Europe · Asia Pacific · Latin America · Middle East and Africa
  • Published In01 Apr 2026
  • Report CodeCMI8979
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Global Keytruda Market, By Treatment Regimen
      • Global Keytruda Market, By Indication
      • Global Keytruda Market, By Dosage Regimen
      • Global Keytruda Market, By Payer Type
      • Global Keytruda Market, By Gender
      • Global Keytruda Market, By Distribution Channel
      • Global Keytruda Market, By End User
      • Global Keytruda Market, By Region
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Driver
    • Restraint
    • Opportunity
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
    • Industry Trends
  4. Global Keytruda Market, By Treatment Regimen, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Monotherapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Combination therapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  5. Global Keytruda Market, By Indication, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Melanoma
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Non‑Small Cell Lung Cancer (NSCLC)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Malignant Pleural Mesothelioma (MPM)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Head and Neck Squamous Cell Carcinoma (HNSCC)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Classical Hodgkin Lymphoma (cHL)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Primary Mediastinal Large B‑Cell Lymphoma (PMBCL)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Urothelial Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Microsatellite Instability‑High/Mismatch Repair Deficient (MSI‑H/dMMR) Solid Tumors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • MSI‑H/dMMR Colorectal Cancer (CRC)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Gastric Adenocarcinoma/Gastroesophageal Junction (GEJ) Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Esophageal/GEJ Carcinoma
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Cervical Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Hepatocellular Carcinoma (HCC)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Biliary Tract Cancer (BTC)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Merkel Cell Carcinoma (MCC)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Renal Cell Carcinoma (RCC)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Endometrial Carcinoma
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Tumor Mutational Burden‑High (TMB‑H) Solid Tumors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Cutaneous Squamous Cell Carcinoma (cSCC)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Triple‑Negative Breast Cancer (TNBC)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  6. Global Keytruda Market, By Dosage Regimen, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Fixed-Dose (Adult)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
        • 200 mg every 3 weeks
        • 400 mg every 6 weeks
    • Weight-Based (Pediatric)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • 2 mg/kg (up to 200 mg) every 3 weeks
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  7. Global Keytruda Market, By Payer Type, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Public
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Private
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  8. Global Keytruda Market, By Gender, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Male
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Female
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  9. Global Keytruda Market, By Distribution Channel, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Hospital pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Specialty/Retail pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Online pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  10. Global Keytruda Market, By End User, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Academic and Research Cancer Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Specialty Cancer Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Ambulatory Infusion Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  11. Global Keytruda Market, By Region, 2021 - 2033, Value (USD Bn)

    • Introduction
      • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
      • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, By Treatment Regimen, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Dosage Regimen, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Payer Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Treatment Regimen, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Dosage Regimen, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Payer Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Treatment Regimen, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Dosage Regimen, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Payer Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Treatment Regimen, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Dosage Regimen, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Payer Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Treatment Regimen, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Dosage Regimen, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Payer Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Treatment Regimen, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Dosage Regimen, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Payer Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
        • South Africa
        • North Africa
        • Central Africa
  12. Competitive Landscape

    • Merck & Co., Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
  13. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  14. References and Research Methodology

    • References
    • Research Methodology
    • About us

*Browse 32 market data tables and 28 figures on ‘Keytruda Market' - Global forecast to 2033